FCT

FCT (Functional Cell Technologies) was a biotechnology company that specialized in the development of functional cell-based assays for drug discovery and clinical research. The company's core technology utilized advanced flow cytometry and automated cell analysis to measure the physiological responses of primary cells and cell lines to various stimuli. By providing high-throughput data on cell function rather than just molecular markers, FCT's platform helped pharmaceutical companies better predict drug efficacy and toxicity early in the development process. The company was eventually acquired by Molecular Devices in 2005 to integrate its unique cell analysis capabilities into their broader life sciences instrumentation portfolio.